close

PerkinElmer, Inc., a technology company, focuses on improving the health and safety of people and their environment through scientific solutions and components. The company's Human Health business develops research and diagnostic instrumentation technologies, as well as clinical resources and support services to fight illness, provide medical insight, and develop therapies. PerkinElmer has the portfolios of functional cellular science research technologies, as well as GPCR and kinase products used in researching approximately 75% of drug pathways. It also engages in pre-natal and newborn screening; and umbilical cord blood storage. This business focuses on cellular research; clinical genetics and diagnostics; custom services; drug discovery; life science research; medical imaging technologies; and pharmaceutical development and manufacturing areas. PerkinElmer's Environmental Health business develops analytical instrumentation, illumination and detection technologies, and support services to improve the quality and sustainability of the environment; the integrity and safety of everything that can be touched and consumed; and the security of the surroundings. Its environmental monitoring, consumer safety solutions, and renewable energy testing technologies focuses on a cleaner, safer planet. PerkinElmer's Environmental Health business focuses on consumer product safety; environmental analysis; food, flavors, and agriculture analysis; forensic analysis; laboratory services; and illumination and detection technologies renewable energy areas. PerkinElmer was founded in 1931 and is headquartered in Waltham, Massachusetts.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	27.02
Volume	811772
Volume Avg	(mio) 1.19
52 Week High	28.75
52 Week Low	17.45
PE	406.12
PE (group average)	57
EPS Year	0.07
EPS change Q/Q	-91.87%
EPS change Q/Q Yr ago	-4.76%
EPS change Q/Q next Q est	-58.33%
EPS change Y/Y	-73.62%
REV change Q/Q	-4.7%
REV change Q/Q Yr ago	13.8%
EPS next Q est	0.48
EPS next Y est	2.29
Divident Annual	0.28
Dividend Yield	1.04%